Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects

[1]  K. Lesch,et al.  Zur Serotonin-Hypothese der Depression , 1990 .

[2]  D. Murphy,et al.  Serotonin in Major Psychiatric Disorders , 1990 .

[3]  D. Murphy,et al.  Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study. , 1989, Archives of general psychiatry.

[4]  M. Raskind,et al.  The neurobiology of aging: Does it predispose to depression? , 1988, Neurobiology of Aging.

[5]  R. Shank,et al.  Block of conditioned avoidance responding in the rat by substituted phenylpiperazines. , 1988, European journal of pharmacology.

[6]  T. Insel,et al.  Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. , 1988, Archives of general psychiatry.

[7]  T. Insel,et al.  Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. , 1987, Archives of general psychiatry.

[8]  P. Chopin,et al.  Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission , 1987 .

[9]  D. Murphy,et al.  Long‐term imipramine treatment enhances locomotor and food intake suppressant effects of m‐chlorophenylpiperazine in rats , 1987, British journal of pharmacology.

[10]  L. George,et al.  The epidemiology of depression in an elderly community population. , 1987, The Gerontologist.

[11]  M. Woodbury,et al.  Suicide in middle age and later life: sex and race specific life table and cohort analyses. , 1987, Journal of gerontology.

[12]  P. Cowen.  Psychotropic drugs and human 5-HT neuroendocrinology , 1987 .

[13]  D. Murphy,et al.  Use of serotonergic agents in the clinical assessment of central serotonin function. , 1986, The Journal of clinical psychiatry.

[14]  D. Middlemiss,et al.  Binding of the Novel Serotonin Agonist 8‐Hydroxy‐2‐(Di‐n‐Propylamino) Tetralin in Normal and Alzheimer Brain , 1986, Journal of neurochemistry.

[15]  D. Murphy,et al.  Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans. , 1985, The Journal of clinical endocrinology and metabolism.

[16]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[17]  S. Iversen.  5-HT and anxiety , 1984, Neuropharmacology.

[18]  M M Weissman,et al.  Lifetime prevalence of specific psychiatric disorders in three sites. , 1984, Archives of general psychiatry.

[19]  D. Charney,et al.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.

[20]  N. Sims,et al.  Biochemical Evidence of Selective Nerve Cell Changes in the Normal Ageing Human and Rat Brain , 1983, Journal of neurochemistry.

[21]  R. Samanin,et al.  Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats , 1981, Neurochemistry International.

[22]  A. Quattrone,et al.  Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. , 1981, European journal of pharmacology.

[23]  M. Åsberg,et al.  Monoamine metabolites in CSF and suicidal behavior. , 1981, Archives of general psychiatry.

[24]  L. Antkiewicz-Michaluk,et al.  5‐Hydroxytryptamine‐like properties of m‐chlorophenylpiperazine: comparison with quipazine , 1980, The Journal of pharmacy and pharmacology.

[25]  A. Lewandowska,et al.  Central serotoninmimetic action of phenylpiperazines. , 1980, Polish journal of pharmacology and pharmacy.

[26]  J. Shih,et al.  The alteration of serotonin binding sites in aged human brain. , 1978, Life sciences.

[27]  J. Meek,et al.  Aging-induced Changes in Acetylcholine and Serotonin Content of Discrete Brain Nuclei , 1977 .

[28]  M. Åsberg,et al.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.

[29]  B. Johansson,et al.  Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. , 1971, Neuropharmacology.

[30]  M. Bowers,et al.  Relationship of Monoamine Metabolites in Human Cerebrospinal Fluid to Age , 1968, Nature.